KIT and infarction: Preclinical studies showed that these c-kit+ CSCs regenerated both the hearts of rats (64, 69) and mice (65, 70) post-infarction via the formation of new myocytes and vasculature, and protected the preexisting cardiomyocytes from apoptosis through the secretion of IGF-1 (71, 72).